Skip to content

Clinical trials

Phase 1 Carcinoma, Renal Cell trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Phase: Phase 1 Country / region: Belgium Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20131
20161
20172
20181
20193
20212
20223
20232
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated5
Active, not recruiting4
Completed4
Recruiting4
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Exelixis3
Incyte Corporation2
ADC Therapeutics S.A.1
Bayer1
EMD Serono Research & Development Institute, Inc.1
Eli Lilly and Company1
Genentech, Inc.1
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company1
Sairopa B.V.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell18
Carcinoma, Non-Small-Cell Lung9
Colorectal Neoplasms7
Carcinoma, Transitional Cell6
Melanoma5
Squamous Cell Carcinoma of Head and Neck5
Neoplasms4
Endometrial Neoplasms3
Ovarian Neoplasms3
Stomach Neoplasms3

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.